The State Administration of Market Supervision announced the sixth batch of typical cases of illegal investigation and treatment of epidemic d

　　According to the website of the State Administration of Market Supervision and Administration, in February, the State Administration of Market Supervision and Administration guided the local market supervision departments to continue to strengthen the supervision and law enforcement efforts, to fully maintain the market order of epidemic drugs and medical supplies after the Spring Festival, and to protect the legitimate rights and interests of the people in purchasing and using drugs. The local market supervision departments continued to carry out the special action of stabilizing the price and quality of epidemic drugs and medical supplies, put the case on file quickly and deal with it strictly, maintain the high pressure situation, and investigate and deal with a number of illegal cases such as raising prices and illegal sales of drugs and medical devices. In order to give full play to the role of warning and education of typical cases and guide operators to operate in compliance with the law, the sixth batch of typical cases involving epidemic drugs and medical supplies are hereby announced.

　　1、 The case of unqualified masks produced and sold by Tianjin Yamasaki Paper Products Co., Ltd

　　On December 12. 2022. the Market Supervision Bureau of Wuqing District, Tianjin received a clue that the "information to be provided by the supplier" and "identification" items marked on the outer package of the non-medical mask produced by Tianjin Yamasaki Paper Products Co., Ltd. did not comply with the GB2626-2019 standard, and the inspection conclusion was unqualified. According to the investigation, the company entrusted a company in Suzhou to produce the above unqualified batches of masks and sell them to a company in Beijing. The above actions of the company violated the provisions of Articles 12. 32 and 39 of the Product Quality Law. On February 6. 2023. the Market Supervision Bureau of Wuqing District imposed an administrative penalty of confiscating 1952 yuan of illegal income and a fine of 12800 yuan on the company's production and sales of unqualified masks.

　　2、 Inner Mongolia Chunyu Pharmaceutical Co., Ltd. bid up the price

　　On January 5. 2023. the market supervision bureau of Saihan District, Hohhot City, Inner Mongolia Autonomous Region found that since December 8. 2022. Inner Mongolia Chunyu Pharmaceutical Co., Ltd. has sold ibuprofen sustained-release capsules at a high price, with a purchase price of 0.25 yuan per capsule, a sales price of 1.5 yuan per capsule, and a mark-up rate of 495%. The above behavior of the company violates the provisions of Item (3) of Article 14 of the Price Law, and constitutes an illegal act of driving up prices. On January 31. 2023. Saihan District Market Supervision Bureau imposed an administrative penalty of 50000 yuan according to law.

　　3、 Cases of illegal sale of drugs and medical devices in Yiguo Children's Amusement Park, Xihe District, Fuxin City, Liaoning Province

　　On December 14. 2022. the Market Supervision Bureau of Xihe District, Fuxin City, Liaoning Province, according to relevant clues, carried out law enforcement inspection on Yiguo Children's Amusement Park in Xihe District. According to the investigation, the amusement park carried out the activities of purchasing toys or handling membership cards to give Lianhua Qingwen capsule and antigen detection kit at the business site without obtaining the drug business license and medical device business license. It purchased 2000 Lianhua Qingwen Capsules and 800 antigen detection kits, with a total value of 27200 yuan. His behavior violates the provisions of Article 51 of the Drug Administration Law and Article 42 of the Regulations on the Supervision and Administration of Medical Devices, and constitutes an illegal act of trading drugs without a drug trading license and engaging in the business activities of Class III medical devices without a license. According to the relevant provisions of the Drug Administration Law and the Regulations on the Supervision and Administration of Medical Devices, on February 20. 2023. the Market Supervision Bureau of Xihe District imposed an administrative penalty of 155000 yuan according to law.

　　4、 False publicity case of Shanghai Fanji Brand Management Co., Ltd

　　According to the clue investigation, Shanghai Fengxian District Market Supervision Bureau found that Shanghai Fanji Brand Management Co., Ltd. had put up a mask in the online store, marked as "MR.ERA KF94 Fish Mouth Willow Leaf Korean 3D Three-dimensional Four-layer Protection". The product parameters and physical photos of the mask were clearly marked as KF94. After verification, KF94 is the Korean mask standard, for the diameter of 0.4 μ The filtration rate of particulate matter in m is more than 94%, and the masks sold by the company are not foreign-related masks and have not been tested in South Korea. The company uses misleading propaganda to mislead consumers to buy. As of the time of the case, the company had sold 516 masks with a sales amount of 3044.4 yuan. The above actions of the company violated the provisions of Article 8. paragraph 1. of the Anti-Unfair Competition Law. On January 16. 2023. Fengxian District Market Supervision Bureau imposed an administrative penalty of 20000 yuan according to law.

　　5、 The Maoshengji Medical Clinic in Tongzhou, Nantong, Jiangsu Province issued a false drug advertisement without examination

　　On December 14. 2022. the Market Supervision Bureau of Tongzhou District, Nantong City, Jiangsu Province, conducted an on-site inspection of Tongzhou Maoshengji Internal Medicine Clinic, and found that the company published the following text on the LED screen: "Traditional Chinese medicine shows its talents in special periods, and patients infected with COVID-19 turn negative after taking Huayaokang Qingfei Decoction for one day (there are individual differences in the time of turning negative)". The investigation found that the "Huayao Kang Qingfei Decoction" mentioned in the above advertisement was a quasi brand traditional Chinese patent medicines and simple preparations Qingfei Shisan powder produced by a pharmaceutical company after being decocted with water. The advertisement advertised that the drug could make COVID-19 infected patients "turn negative", which was inconsistent with the functions and indications in the drug manual, and the company had no relevant evidence at the scene. The clinic issued false drug advertisements without examination, in violation of the provisions of Article 4. Paragraph 1. Article 16. Paragraph 2 and Article 46 of the Advertising Law. On February 27. 2023. the Tongzhou District Market Supervision Bureau of Nantong City imposed an administrative penalty of 20000 yuan according to law.

　　6、 Case of Kangshou Drugstore in Gangqu District, Jiaxing City, Zhejiang Province

　　On December 21. 2022. the Port Branch of Jiaxing Market Supervision Bureau of Zhejiang Province carried out law enforcement inspection on Kangshou Drugstore in Jiaxing Port District according to the reporting clues. According to the investigation, the drugstore purchased ibuprofen tablets at the price of 22 yuan/bottle on December 12. and sold the batch of drugs at the price of 128 yuan/bottle on December 18. The purchase price of ibuprofen tablets in the drugstore increased from 2.28 yuan/bottle to 22 yuan/bottle, about 10 times higher than that before the adjustment of epidemic policy; The sales price rose from 3 yuan/bottle to 128 yuan/bottle, up about 41 times. Although the purchase cost of drugs in the drugstore has increased, the increase of sales price is significantly higher than the increase of cost, which violates the provisions of Item (3) of Article 14 of the Price Law and constitutes an illegal act of raising prices. On February 24. 2023. Jiaxing Municipal Market Supervision Bureau imposed an administrative penalty of confiscating illegal income of 17579.37 yuan and imposing a fine of 35158.74 yuan.

　　7、 Sichuan Sanqitang Pharmacy Co., Ltd. operates Class III medical devices without qualification certificates

　　On December 15. 2022. the Market Supervision Bureau of Chongzhou City, Sichuan Province inspected Sichuan Sanqitang Pharmacy Co., Ltd. Upon investigation, the company operated novel coronavirus antigen rapid detection reagents without qualification certificates, and its behavior violated the provisions of Article 55 of the Regulations on the Supervision and Administration of Medical Devices. On February 10. 2023. Chongzhou Municipal Market Supervision Bureau imposed an administrative penalty of 30000 yuan according to law.

　　8、 Case of Sinopharm Holding Qiandongnan Pharmaceutical Co., Ltd. to bid up drug prices

　　On January 16. 2023. the Market Supervision Bureau of Qiandongnan Prefecture of Guizhou Province carried out law enforcement inspection on Sinopharm Holding Qiandongnan Pharmaceutical Co., Ltd. According to the investigation, the purchase price of dexamethasone sodium phosphate injection sold by the company was 0.58 yuan/piece in November 2022. the sales price was 0.63 yuan/piece, the purchase price was 0.7 yuan/piece in December 2022. and the sales price was raised to 9.8 yuan/piece from January 2023. the purchase price increased by 20.69%, and the sales price increased by 1455.56%. By the time of the case, the company had sold 38780 of the 50000 pieces purchased, with a sales amount of 380044 yuan. Although the purchase cost of drugs of the company has increased, the increase of drug price is significantly higher than the increase of cost, which violates the provisions of Item (3) of Article 14 of the Price Law and constitutes an illegal act of raising prices. On February 15. 2023. Qiandongnan Prefecture Market Supervision Bureau imposed an administrative penalty of 700000 yuan according to law.

Shandong Zhushi Pharmaceutical Group Co., Ltd., founded in 2003, has more than 5000 registered employees. After years of development, it has developed into a diversified industrial cluster integrating medical devices, polymers, cosmetics, health food, daily necessities and biological reagent production, enterprise management consulting and training, real estate economy, pharmaceutical transportation, pharmaceutical printing, etc.

Adhering to the concept of life, health and happiness, the Group provides you with full chain health services.

HOT

NEW